Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eric Poma, Ph.D.

Eric Poma, Ph.D. is recorded as Board Member and CEO at Calidi Biotherapeutics, Inc. (CLDI). Calidi Biotherapeutics, Inc. reported in an 8-K filed April 23, 2025 that Eric Poma, Ph.D. was appointed member of the Board of Directors, effective April 22, 2025. Calidi Biotherapeutics, Inc. reported in an 8-K filed April 23, 2025 that Eric Poma, Ph.D. was appointed Chief Executive Officer, effective April 22, 2025.

“Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of its Chief Executive Officer (“CEO”), Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi (“Board”), effective April 22, 2025.”
Calidi Biotherapeutics, Inc. Form 8-K, filed April 23, 2025 · Read the filing
“As of the Effective Date of this Agreement, Executive shall be employed by the Company as the Chief Executive Officer and perform such other duties as are customarily associated with this position and assigned to Executive by the Board of Directors of the Company (the "Board").”
Calidi Biotherapeutics, Inc. Form 8-K, filed April 23, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Calidi Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.